ClinicalTrials.Veeva

Menu

Correlation Between Optical Coherence Tomography Angiography and Photopic Negative Response in Patients With Glaucoma

B

Benha University

Status

Completed

Conditions

Open Angle Glaucoma

Treatments

Diagnostic Test: Optical Coherence Tomography- Angiography
Diagnostic Test: Photopic negative response

Study type

Observational

Funder types

Other

Identifiers

NCT05104294
RC-9-11-01

Details and patient eligibility

About

Open angle glaucoma (OAG) is considered a common cause of irreversible vision loss worldwide. It is an optic neuropathy associated with progressive loss and degeneration of the retinal ganglion cell layer (RGC) and its axons (retinal nerve fiber layer; RNFL), which lead to neuroretinal rim excavation and corresponding visual field defects.

Full description

Open angle glaucoma (OAG) is considered a common cause of irreversible vision loss worldwide. It is an optic neuropathy associated with progressive loss and degeneration of the retinal ganglion cell layer (RGC) and its axons (retinal nerve fiber layer; RNFL), which lead to neuroretinal rim excavation and corresponding visual field defects.

OCT Angiography (OCTA) is a promising tool for diagnosing and monitoring glaucomatous patients. It can evaluate glaucomatous damage and assess the ganglion cells' health by measuring blood flow within the optic nerve and the retina Correlation between vascular , structural and functional changes of the peripapillary retinal nerve fiber (RNFL) and macular/ganglion cell complex (GCC) can lead to early detection of glaucomatous changes.

Enrollment

76 patients

Sex

All

Ages

35 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age of 30 years or older for both control and glaucoma groups.
  • Spherical equivalent (SE) between -2 and +2 D.
  • No history of previous eye surgery, trauma, or systemic diseases.

Exclusion criteria

  • Spherical equivalent greater than +/- 2.00 diopters (D).
  • Media opacity as (cataract or corneal scar).
  • Any history of ocular surgeries or trauma.
  • Optic nerve anomaly or other retinal diseases.
  • Unreliable visual field tests (33% fixation losses, false positive, and false- negative results).

Trial design

76 participants in 3 patient groups

mild Primary Open Angle Glaucoma group (Group I)
Description:
28 eyes of 16 patients with mild primary open angle glaucoma as group I.
Treatment:
Diagnostic Test: Photopic negative response
Diagnostic Test: Optical Coherence Tomography- Angiography
moderate to severe Primary Open Angle Glaucoma group (Group II)
Description:
44 eyes of 24 patients with moderate to severe primary open angle glaucoma as group II.
Treatment:
Diagnostic Test: Photopic negative response
Diagnostic Test: Optical Coherence Tomography- Angiography
Control Group
Description:
80 eyes of 40 healthy subjects as control group.
Treatment:
Diagnostic Test: Photopic negative response
Diagnostic Test: Optical Coherence Tomography- Angiography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems